Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Odonate Therapeutics, Inc. (ODT)
|
Add to portfolio |
|
|
|
| Price: |
$3.35
| | Metrics |
| OS: |
38.5
|
M
| |
|
|
| Market cap: |
$129
|
M
| |
|
|
|
Net cash:
|
$95
|
M
| |
$2.47
|
per share
|
|
EV:
|
$33.9
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 2.6 | 0.0 |
| Revenue growth | | | | -100.0% | | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 3.1 | 0.2 |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | -0.5 | -0.2 |
| Gross margin | | | | | -17.7% | |
| Selling, general and administrative | | | | | | 0.0 |
| Research and development | 117.0 | 104.0 | 79.9 | 27.9 | | |
| General and administrative | 10.4 | 10.9 | 10.8 | 4.8 | 0.5 | 0.0 |
| EBIT | -127.4 | -114.9 | -90.8 | -32.7 | -3.5 | -0.2 |
| EBIT margin | | | | | -135.3% | |
| Pre-tax income | -126.4 | -111.8 | -89.0 | -32.7 | -3.1 | 0.0 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Net income | -126.4 | -111.8 | -89.0 | -32.7 | -3.1 | 0.0 |
| Net margin | | | | | -117.7% | |
| |
| Diluted EPS | ($3.84) | ($4.05) | ($3.64) | ($2.31) | ($0.54) | |
| Shares outstanding (diluted) | 32.9 | 27.6 | 24.5 | 14.2 | 5.8 | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|